The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism

Introduction: A number of anti-diabetic treatments have been favored during the continuing spread of the current SARS-CoV-2 pandemic. Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are a group of antidiabetic drugs, the glucose-reducing effect of which is founded on augmenting glucose-dependen...

Full description

Bibliographic Details
Main Author: Banerjee, Yajnavalka (author)
Other Authors: Stoian, Anca Pantea (author), Silva-Nunes, José (author), Sonmez, Alper (author), Rizvi, Ali A. (author), Janez, Andrej (author), Rizzo, Manfredi (author)
Format: article
Language:eng
Published: 2021
Subjects:
COVID-19
SARS-CoV-2
GLP-1RA
Coronavirus
Diabetes
Pandemic
Online Access:http://hdl.handle.net/10400.21/13684
Country:Portugal
Oai:oai:repositorio.ipl.pt:10400.21/13684

Internet

http://hdl.handle.net/10400.21/13684

Similar Items